Lupin has incorporated a wholly owned subsidiary in Thailand in the name and style ‘Lupin (Thailand)’ on April 17, 2026. Lupin (Thailand) shall be engaged to import, market, promote, distribute and sell pharmaceutical products in Thailand.
Lupin (Thailand) has been incorporated with a registered and paid up capital of 3,000,000 Baht divided into 600,000 Shares of par value of 5 Baht each.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
